357 related articles for article (PubMed ID: 7515115)
1. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement.
Imperiale TF; Speroff T
JAMA; 1994 Jun; 271(22):1780-5. PubMed ID: 7515115
[TBL] [Abstract][Full Text] [Related]
2. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
[TBL] [Abstract][Full Text] [Related]
3. Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin.
Colwell CW; Froimson MI; Mont MA; Ritter MA; Trousdale RT; Buehler KC; Spitzer A; Donaldson TK; Padgett DE
J Bone Joint Surg Am; 2010 Mar; 92(3):527-35. PubMed ID: 20194309
[TBL] [Abstract][Full Text] [Related]
4. Danaparoid in the prevention of thromboembolic complications.
Skoutakis VA
Ann Pharmacother; 1997; 31(7-8):876-87. PubMed ID: 9220051
[TBL] [Abstract][Full Text] [Related]
5. Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement.
Harris WH; Salzman EW; Athanasoulis C; Waltman AC; Baum S; DeSanctis RW
J Bone Joint Surg Am; 1974 Dec; 56(8):1552-62. PubMed ID: 4434023
[No Abstract] [Full Text] [Related]
6. Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery.
Levine MN; Gent M; Hirsh J; Weitz J; Turpie AG; Powers P; Neemeh J; Willan A; Skingley P
Arch Intern Med; 1996 Apr; 156(8):851-6. PubMed ID: 8774203
[TBL] [Abstract][Full Text] [Related]
7. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials.
Eikelboom JW; Quinlan DJ; Douketis JD
Lancet; 2001 Jul; 358(9275):9-15. PubMed ID: 11454370
[TBL] [Abstract][Full Text] [Related]
8. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis.
Roderick P; Ferris G; Wilson K; Halls H; Jackson D; Collins R; Baigent C
Health Technol Assess; 2005 Dec; 9(49):iii-iv, ix-x, 1-78. PubMed ID: 16336844
[TBL] [Abstract][Full Text] [Related]
9. Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis.
Iorio A; Agnelli G
Arch Intern Med; 2000 Aug 14-28; 160(15):2327-32. PubMed ID: 10927730
[TBL] [Abstract][Full Text] [Related]
10. Potent Anticoagulation Does Not Reduce Venous Thromboembolism in High-Risk Patients.
Tan TL; Foltz C; Huang R; Chen AF; Higuera C; Siqueira M; Hansen EN; Sing DC; Parvizi J
J Bone Joint Surg Am; 2019 Apr; 101(7):589-599. PubMed ID: 30946192
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis for venous thromboembolism in total hip arthroplasty: a review.
O'Meara PM; Kaufman EE
Orthopedics; 1990 Feb; 13(2):173-8. PubMed ID: 1689843
[No Abstract] [Full Text] [Related]
12. Anticoagulant and aspirin prophylaxis for preventing thromboembolism after major gynaecological surgery.
Oates-Whitehead RM; D'Angelo A; Mol B
Cochrane Database Syst Rev; 2003; (4):CD003679. PubMed ID: 14583989
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight heparin compared with dextran as prophylaxis against thrombosis after total hip replacement.
Mätzsch T; Bergqvist D; Fredin H; Hedner U
Acta Chir Scand; 1990; 156(6-7):445-50. PubMed ID: 1695053
[TBL] [Abstract][Full Text] [Related]
14. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
15. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty.
Schousboe JT; Brown GA
J Bone Joint Surg Am; 2013 Jul; 95(14):1256-64. PubMed ID: 23864173
[TBL] [Abstract][Full Text] [Related]
17. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
[TBL] [Abstract][Full Text] [Related]
18. [Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].
Marx A; Huhle G; Hoffmann U; Wang LC; Schüle B; Jani L; Harenberg J
Z Orthop Ihre Grenzgeb; 1999; 137(6):536-9. PubMed ID: 10666863
[TBL] [Abstract][Full Text] [Related]
19. Thromboembolism after elective and post-traumatic hip surgery--a controlled prophylactic trial with dextran 70 and low-dose heparin.
Bergqvist D; Efsing HO; Hallböök T; Hedlund T
Acta Chir Scand; 1979; 145(4):213-8. PubMed ID: 386676
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of a low molecular weight heparin (Logiparin) versus dextran as prophylaxis against thrombosis after total hip replacement.
Mätzsch T; Bergqvist D; Fredin H; Hedner U
Acta Chir Scand Suppl; 1988; 543():80-4. PubMed ID: 2461017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
